Non-insulin oral drug(s)-Other Posts on Medivizor
Navigation Menu

Non-insulin oral drug(s)-Other Posts on Medivizor

SGLT-2 inhibitors and lower limb amputation risk in people with type 2 diabetes

Posted by on Jul 29, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study wanted to find out if treating type 2 diabetes with SGLT-2 inhibitors increases the risk of disease in blood vessels or the risk of amputation of the feet. The study found that treating type 2 diabetes with certain SGLT-2 inhibitors such as canagliflozin (Invokana) may be associated with an increased risk of disease in the...

Read More

DPP-4 inhibitor use in type 2 diabetes and the risk of diabetic eye disease

Posted by on Dec 8, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study aimed to investigate if the use of DPP-4 inhibitor drugs for the treatment of type 2 diabetes (T2D) was harmful or helpful in diabetic retinopathy (DR; eye disease). The main finding of this study was that DPP-4 inhibitors did not increase the overall risk of DR. Some background DPP-4 inhibitors (DPP4i) are a type drug used to...

Read More

Do SGLT2 inhibitors prevent cardiovascular complications in type 2 diabetes?

Posted by on Sep 10, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated whether SGLT2 (sodium-glucose co-transporter-2) inhibitors reduced the risk of cardiovascular complications in patients with type 2 diabetes. They found that SGLT2 inhibitors were associated with reduced risk of cardiovascular disease and mortality compared to other treatment types.  Some background...

Read More

A comparison between the effects of Sulfonylurea and Metformin on cardiovascular events in patients with type 2 Diabetes Mellitus

Posted by on Feb 23, 2013 in Diabetes mellitus | 1 comment

In a nutshell The present study compared the effects of therapy with either Metformin or Sulfonylureas (Glyburide, Glipizide) on cardiovascular events (heart attack and stroke) or death in patients with type 2 diabetes mellitus (DM2). The main findings were that treatment with Sulfonylurea was associated with an increased risk of cardiovascular disease...

Read More